Assessing the reversibility of bronchiectasis with deep learning - Authors' reply
Isabelle Sermet-Gaudelus1, Daan Caudri2, Punit Makani2
1Centre de Référence Maladies Rares, Mucoviscidose et Maladies Apparentées, Site Constitutif Pédiatrique, Hôpital Necker Enfants Malades, 75015 Paris, France; Université de Paris, CNRS, INSERM, Institut Necker-Enfants Malades, Paris, France; European Rare Disease Network-Lung, Frankfurt, Germany.
The Lancet. Respiratory Medicine
|March 5, 2026
Summary
No abstract available in PubMed .


